PharmaLectures.com

Courses › Pharma training by line of business › Europe playbook for the finished-dose generic company: licences, documents, customers, cost

Europe playbook for the finished-dose generic company: licences, documents, customers, cost

Your generic dossier clears validation the first time, and your launch date holds.

  • 12 audio modulesthree lengths each
  • 2 h to 10 hbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • Finished-dose generic companywho it is written for

Why this training matters

The assessor finds the bioequivalence report missing from Module 5 of your application. The assessor raises a request for information, the clock stops and the launch date slips. A competitor takes the tender, and your team spends weeks rebuilding a dossier that should have gone in complete.

What changes after this course

Your team picks the right procedure, files a complete Common Technical Document and gives management a timeline it can plan around. You hold a certificate for every learner and a training record for each person, ready for the next inspector.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

Your regulatory affairs team picks the route without waiting for an outside adviser. They compare the centralised, decentralised and mutual recognition procedures against the product in front of them, and they place every document in the Common Technical Document where the assessor looks for it. The surprise request for information stops arriving.

Inspection day changes for quality assurance. The inspector asks about batch records, change control and the quality system, and your staff answer from files that already line up with Good Manufacturing Practice Part I and International Council for Harmonisation Q10. When a change comes in, your team sorts it into Type IA, Type IB or Type II under the Classification Guideline and files it correctly.

Supply chain managers check the Falsified Medicines Directive safety features and the Good Distribution Practice requirements on a route before the first pallet moves. Next to them, your pharmacovigilance lead keeps the Pharmacovigilance System Master File current, so your Qualified Person for Pharmacovigilance answers an inspector from a file, not from memory.

Business developers bring management a plan with dates in it: data exclusivity ends here, the Supplementary Protection Certificate runs to there, this national pricing body decides by then. Resources go to the markets where your generic can win a tender, and the others wait.

Who needs this training

  • Regulatory Affairs Manager

    A new generic sits on the portfolio list and the team argues over the decentralised or the mutual recognition procedure. You get the criteria to settle it and a timeline you can defend to management.

  • Quality Assurance Director

    The national competent authority has announced an inspection. You need a quality system and records that answer Good Manufacturing Practice and International Council for Harmonisation Q10 questions without anyone hunting for files.

  • Supply Chain Manager

    A shipment crosses several borders and a wholesaler asks for proof of the safety features and the temperature record. You get the checks that let you answer on the spot.

  • Pharmacovigilance Lead

    The Pharmacovigilance System Master File is due for review and Good Pharmacovigilance Practices Modules I-XVI look like a wall. You get the order to work in and the file structure an inspector expects.

  • Market Access and Business Development Manager

    Management wants a launch plan by Friday for a country whose pricing rules nobody on the team has read. You get the reimbursement, tender and exclusivity checks to fill the plan.

Roles: Owner, CEO and board, Business development and export sales, Regulatory affairs

Businesses: Finished-dose generic company

Countries: India, China, Türkiye, Korea, Japan, Taiwan, Egypt, Gulf and MENA, Brazil and Latin America, Pakistan, Bangladesh and Vietnam, United States, Europe

Selling into: Europe and the UK

Courses are in English. Other languages on request.

After this course your people can

  1. Choose between the centralised, decentralised and mutual recognition procedures for a named generic product and write down the reason.
  2. Place every document of a generic dossier in the right part of Modules 1 to 5 of the Common Technical Document.
  3. Sort a post-authorisation change into Type IA, Type IB or Type II using the Classification Guideline.
  4. Outline a Pharmacovigilance System Master File that an inspector can follow from the first page.
  5. Check a transport route against Good Distribution Practice and the Falsified Medicines Directive safety features before shipping.
  6. Calculate when data exclusivity and a Supplementary Protection Certificate end for a reference product, and mark both dates in the launch plan.
  7. Draw the critical path of a European submission with dates, owners and a buffer for each clock-stop.

What the company gets

  • Dossiers go in complete, so validation does not stop for a missing report in Module 3 or Module 5.
  • An inspector asks about your Pharmacovigilance System Master File and gets a straight answer from the file itself.
  • Your team shows a certificate for every learner and a training record for each person when the inspector asks who was trained.
  • Management gets a timeline and a cost estimate for each market entry, with the exclusivity dates already marked.
  • Supply chain staff check each route against Good Distribution Practice before shipping, so a route problem is found on paper, not at the wholesaler's door.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 12 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing2 h10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard5 h25 min a module, for regulatory, quality and business-development staff
Expanded10 h50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Owner, CEO and boardBriefing2 h
Business development and export salesBriefing2 h
Regulatory affairsStandard5 h

Course outline: 12 modules

12 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Choose your legal route under Directive 2001/83/EC and Regulation 726/2004

    • How to tell in one meeting whether your product goes by Article 10(1) or needs another legal basis.
    • Why the European Medicines Agency and a national agency want different things from the same file.
    • The scope question in Regulation 726/2004 to settle before your team commits to a route.
  2. 2Pick the right Marketing Authorisation Procedure for your generic product

    • When Article 10(3) is your route and when a plain generic application will do.
    • How to choose between the centralised, decentralised and mutual recognition procedures in one sitting.
    • What to do when a Concerned Member State objects and your timetable is already fixed.
  3. 3Assemble a Common Technical Document dossier that clears validation

    • How to place each document in Modules 1 to 5 so the assessor finds it without asking.
    • What the European Medicines Agency bioequivalence guideline expects in your Module 5 study report.
    • Why a gap in Module 3 stops the clock, and the check that finds it before you file.
  4. 4Run manufacturing to Good Manufacturing Practice and show it to inspectors

    • What the inspector asks on the production floor and the record that answers it.
    • How to bring International Council for Harmonisation Q10 into the daily routine of your quality unit.
    • The record gaps in Good Manufacturing Practice Part I that turn into inspection findings.
  5. 5Sort every change into the right category with the Classification Guideline

    • How to sort a change into Type IA, Type IB or Type II before anyone files.
    • When you notify first and when you must wait for approval before the change goes live.
    • The variation mistake that sends a filing back, and the checklist step that prevents it.
  6. 6Set up your Good Pharmacovigilance Practices system to Modules I-XVI

    • How to build a Pharmacovigilance System Master File an inspector can follow without your help.
    • What your Qualified Person for Pharmacovigilance signs, checks and keeps on file.
    • Which of the Good Pharmacovigilance Practices modules your small team needs first, and which can wait.
  7. 7Set a generic price that works across European reimbursement models

    • How to present your product data to a national pricing body so the first review ends in a decision.
    • Why one pricing model fails in the next country, and how to build a price you can adjust.
    • The reference pricing rules that pull your price down in one market after you launch in another.
  8. 8Apply the Falsified Medicines Directive and Good Distribution Practice

    • How to fit the unique identifier and anti-tampering device into your packing line plan.
    • The Good Distribution Practice checks that stop a temperature excursion before it reaches a wholesaler.
    • What to check on a transport route so a delayed lorry does not become a recall.
  9. 9Win tenders by meeting European procurement agencies on their terms

    • How to put your product in front of a national procurement agency in the form it scores.
    • The data a wholesaler or hospital group asks for before it will stock your medicine.
    • Why you read the tender calendar before you set the price list.
  10. 10Clear patent barriers and track data exclusivity periods

    • How to track data exclusivity and market protection dates for each reference product.
    • The freedom-to-operate check that finds a blocking patent before your launch stock is made.
    • How a Supplementary Protection Certificate moves your launch date past the basic patent expiry.
  11. 11Write a market entry business plan that gets internal resources approved

    • How to forecast sales for a new generic launch without borrowing figures from the last one.
    • The way to set your product apart from older generics already on the pharmacy shelf.
    • Why local entry costs belong in the plan on day one, and where to find them.
  12. 12Plot timelines and costs for each European regulatory submission

    • How to draw the critical path for a centralised and a national submission on one page.
    • The bottlenecks that stretch a timeline, and where to place a buffer for each.
    • What to put in the launch schedule so a clock-stop becomes a planned event, not a crisis.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

12 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 2 h in the briefing length and 10 h in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for Finished-dose generic company. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 108 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team